Carson Wealth (CWM LLC)
LRMR icon

Carson Wealth (CWM LLC)’s Larimar Therapeutics LRMR Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$289K Buy
64,126
+31,495
+97% +$126K ﹤0.01% 2412
2025
Q4 		$124K Sell
32,631
-3,382
-9% -$13.2K ﹤0.01% 2907
2025
Q3 		$116K Buy
36,013
+3,361
+10% +$12.6K ﹤0.01% 2860
2025
Q2 		$94K Buy
32,652
+21,948
+205% +$50.8K ﹤0.01% 2783
2025
Q1 		$23K Buy
10,704
+10,655
+21,745% +$33.7K ﹤0.01% 3575
2024
Q4 		$0 Buy
49
+32
+188% +$211 ﹤0.01% 5045
2024
Q3 		$0 Buy
17
+4
+31% +$32 ﹤0.01% 4994
2024
Q2 		$0 Buy
13
+12
+1,200% +$92 ﹤0.01% 4773
2024
Q1 		$0 Buy
+1
New +$8 ﹤0.01% 4547
2023
Q4 		– Sell
-86
Closed – – 4353
2023
Q3 		$0 Buy
+86
New +$325 ﹤0.01% 4367

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Carson Wealth (CWM LLC)'s LRMR Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Larimar Therapeutics (LRMR) stake by 97% in Q1 2026, buying an estimated $126K and bringing the position to 64,126 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #2412.

Carson Wealth (CWM LLC) first reported a position in LRMR in Q3 2023 and has held it in 10 quarters since. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • Carson Wealth (CWM LLC) held 64,126 shares of Larimar Therapeutics worth $289K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 31,495 Larimar Therapeutics shares in Q1 2026, an estimated $126K.
  • Larimar Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2412 holding.
  • Carson Wealth (CWM LLC) first reported a position in Larimar Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.